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used by 40%/42% of placebo-lvardenafil-treated patients. The mean change from pre- 
treatment standing SBP/DBP (mmHg). and HR (bpm) in the subgroup having post-dose 
data is summarized below. 
Treatment Placebo Vardenafil 
Group mean (SD) mea” (SD) 
n SBP DBP HR n SBP DBP HR 
All Patients 1 -0.1 -0.02 (10.1) -0.2 5 -4.6 -3.1 (6.5) 2.0 
6 (15.7) (10.4) 2 (13.9) (10.3) 
3 0 
No HTM 9 -1.6 -0.4 (9.4) -0.4 2 -4.2 -2.6 (8.4) 2.0 
3 (15.6) (10.6) 7 (12.2) (10.1) 
1 
21 HTM 9 1.5 0.4 (10.9) 0.1 2 -5.1 -3.7 (6.7) 1.9 
0 (15.7) (10.0) 4 (15.6) (10.5) 
9 
In patients on placebo +I- HTM, no consistent changes in BP and HR were seen. Vard- 
enafil was associated with mild reduction in BP and small increase in HR. Concomiksnt 
HTM minimally incrementally reduced SBPlDBP which were generally similar across 
HTM (ACE-I, Ca+2 antagonist, alpha or beta-blockers. diuretic. or ARB). Incidence of 
angina, arryhythmia, MI or syncope was low and similar irrespective of treatment. 
Conclusion: In this study, concomitant HTM/vardenafil use did not result in vital sign 
changes of clinical concern compared to those observed by vardenafil alone. 
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Jacob Joseph, Patrick Kennedy, Kerrey Roberto, Abeer Washington. Nawal Shekhawat, 
Lija Joseph, Richard H. Kennedy, University of Arkansas for Medical Sciences, Little 
Rock, AR, Central Arkansas Veterans Healthcare. Little Rock, AR 
We have recently reported the novel association of hyperhomocysteinemia (Hhe) with 
adverse cardiac remodeling in hypertension (Joseph et al, American Journal of Physiol- 
ogy, In Press). Specifically we demonstrated that Hhe increased myocardial collagen Iev- 
els and worsened diastolic function in spontaneously hypertensive rats (SHR). The 
present study was undertaken to further characterize the mechanisms by which Hhe 
altered collagen levels in the SHR model. 
Methods: Left ventricular myocardial tissue homogenates from SHRs given one of three 
diets: control, intermediate Hhe-inducing (IH) or severe Hhe-inducing (SH) were used in 
this study. Western blot analysis was done to analyze collagen I and Ill protein levels. 
Gel zymography was used to assess total gelatinolytic adivity of the left ventricular myo- 
cardium. 
Results: Homocysteine levels (micromolar) after 10 weeks of treatment were control 
4.3+/-0.4; IH -47.1+/&l and SH - 203+/-13. 
We observed an increase in collagen I protein level in the Hhe groups as compared to 
control. The level of collagen Ill decreased in both Hhe groups. increasing the type l/Ill 
collagen ratio as compared to control. Total gelatinolflic activity was also increased in 
both Hhe groups. 
Conclusions: The fibrillar collagens type I and III are major determinants of myocardial 
systolic and diastolic function. Collagen type I has high tensile strength, while type Ill col- 
lagen is much more compliant. The increase in the ratio of type l/Ill collagen with Hhe 
offers a potential explanation for the increased myocardial stiffness and diastolic dys- 
function seen in this model. An increase in total gelatinolytic activity accompanied the 
increase in collagen synthesis, similar to other conditions of fibrosis. In conclusion, 
altered collagen metabolism seems to be an importanr determinant of Hhe-induced 
adverse cardiac remodeling. 
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Prevention, Atlanta, GA, Cardiovascular Health Branch, Atlanta, GA 
Background: Deaths from heart disease and stroke have declined in past decades; how- 
ever, national trends in hypertension (HTN)- related mortality have not been assessed. 
Methods: National vital statistics multiple cause mortality files from 1960-1996 were ana- 
lyzed for decedents ages 45 years and older with HTN (International Classification of 
Disease code 401-405) listed as one of up to 20 conditions causing death. Racialiethnlc 
comparisons of HTN-related death were assessed ustng age-standardized and age-spe- 
cific rates (per 100,000). 
Results: The number of decedents with HTN increased from 127,294 in 1960 to 216,809 
in 1996. Overall, the age-standardized rate increased from 265.7 in 1960 to 361.2 in 
1998 which was a relative increase of 33% (95% Cl=3%-64%). Age-standardized death 
rates from 1960 to 1996 were consistently highest among black men. followed (in 
descending order) by black women, white men, and white women. From 1960 to 1996, 
age-specific death rates for HTN-related mortality increased 175% (95% Cl=20%-246%) 
for ages 65 years and older, 28% (95% Cl=4%-55%) for ages 75.84 years, and 6% (95% 
CI=2%-15%) for ages 65-74 years but decreased -6% (95% Cl=-2%. -12%) for ages 45- 
64 years. 
COnclusiOn: HTN-related mortality has increased in the US over the last two decades, 
especially for adults aged 65 years and older. Because the residual lifetime risk for HTN 
among middle-aged and elderly adults is high, this trend is lkkely to continue as the popu- 
lation ages. Prevention of HTN must continue to be pursued and recognized as a strat- 
egy to reduce cardiovascular disease morbidity and mortality, especially among black 
adults. These results also reflect delayed ages for HTN-related mortality. Reductions in 
HTN-related mortality for adults under age 65 years may have been influenced by 
national improvements in detection and use of management strategies during the past 
two decades. 
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Background : Early LV functional abnormalities of hypertension in paediarric age has 
not been extensively investigated. Thus. we non-invasively assessed LV mechanics and 
tissue characterization in hypertensive children 
Methods: 21 untreated pts (aged 12.1*6 yrs ) with renal disease and a recent diagnosis 
(-z 6 months) of hypettension at ambulatory blood pressure monitoring underwent an 
echocardiographic evaluation. Sex- and age-specific cutoff levels for LV mass/heigh+’ 
and relative wall thickness were defined to assess LV geometry, as normal, concentric 
remodeling(CR), concentric hypertrophy(CH), eccentric hypertrophy(EH). As load-inde- 
pendent index of myocardial contractility, the relation between the midwall rate-corrected 
velocity of circumferential fiber shortening and meridional end-systolic stress (mwVCFc- 
s..) was defined. LV diastolic function was evaluated by the mitral flow Indexes (peak E, 
peak A, E/A ratio, deceleration time) and isovolumic relaxation time. Finally. ultrasonic 
tissue characterization of the LV myocardium was performed by integrated backscatter. 
In addition, 35 age- and BSA-matched normal subjects were used as control group. 
Results: LV geometry was abnormal in 5/21 pts (2 CR, 1 CH. 2 EH) (23%). LVMl 
heigh?,? which significantly correlated with mean 24-hours systolic pressure 
(r=0.46;p>0.05) was >51 g/m”’ in 2/21 (9.5%) pts. The mwVCFcs,, relation was nor- 
mal (M+PSD) in all pts. lsovolumic relaxation time was prolonged in 12/21(57%) pts and 
deceleration time in 1 I/21 (52%) pts: peak A was increased in 14/21 (66%) and WA ratio 
was decreased in 12/21 (57%) pis. Finally, compared lo control group, Integrated back- 
scatter analysis did not show significant differences in hypertenswe children. 
Conclusions: Majority of hypertensive children show early abnormal LV filling, sugges- 
tive of impaired diastolic relaxation. Significantly, abnormal LV geometry was detected in 
23% and LVM/height2’ was > 51 s/m *.’ in 9.5% of pts. Thus, an early echocardiogrphic 
evaluation of LV diastolic function and geometry allows us to identify a subset of hyper- 
tensive children with heart damage and increased risk of cardiovascular morbility 
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Background: Our previous studies show that obese children have enhanced LV systolic 
performance and LV hypertrophy. Using traditional mitral inflow indices, diastolic dys- 
function has not been apparent. Tissue Doppler imaging (TDI) indices may be more sen- 
sitive for detecting diastolic dysfunction. Our aim was to compare TDI indices in obese 
versus normal children, and to determine correlates of these indices. 
Methods: 146 obese children had echocardiograms. Diastolic function was assessed by 
TDI indices. TDI indices included the early and late peaks of mitral annular velocity at the 
septum (E-sep, A-sep) and lateral (E&t. A-lat) walls. LV mass, body mass index, and 
blood pressure were measured. These data were compared to normal controls. 
Results: The TDI indices for E waves (E-sep, E-lat) were lower than controls, and the 
Indices for A waves (A-sep, A-lat) were higher than controls (Figure). 
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LV mass correlated with A-lat (r=-0.18, p=O.O3). Systolic blood pressure correli 
A-sep (rc0.19, p=O.O2). There was no correlation with body mass index 
ed with 
COnclusfon:TDI indices were significantly different in obese children. These newer indi- 
ces of diastolic function, may provide a method for serial monitoring for cardiovascular 
disease. Identification of these children could allow for earlier initiation of interventional 
strategies aimed at reducing cardiovascular risk. 
